மூளைக் கட்டி (glioma)

High grade gliomas, particularly glioblastoma, are among the most aggressive brain tumors and are associated with poor outcomes despite standard treatment. Many patients, especially older adults or those with poor general health, are not suitable for surgery and have a life expectancy of less than 12 months. Current standard includes a shortened course of radiotherapy (over 3 weeks) combined with chemotherapy using temozolomide (TMZ), which offers limited survival benefits. This study aims to explore whether delivering radiotherapy in a shorter duration (1 or 2 weeks) at a higher dose, guided …

Sponsor: Tata Memorial Centre
NCT07338539 on ClinicalTrials.gov
கடைசியாக 18 May 2026 அன்னைக்கு பதிவு அப்டேட் செய்யப்பட்டது · நாங்க 20 Oct 2026 அன்னைக்கு பார்த்தோம்